Correlation Between Regen BioPharma and Gemina Laboratories

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Regen BioPharma and Gemina Laboratories at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Regen BioPharma and Gemina Laboratories into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Regen BioPharma and Gemina Laboratories, you can compare the effects of market volatilities on Regen BioPharma and Gemina Laboratories and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Regen BioPharma with a short position of Gemina Laboratories. Check out your portfolio center. Please also check ongoing floating volatility patterns of Regen BioPharma and Gemina Laboratories.

Diversification Opportunities for Regen BioPharma and Gemina Laboratories

-0.53
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Regen and Gemina is -0.53. Overlapping area represents the amount of risk that can be diversified away by holding Regen BioPharma and Gemina Laboratories in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gemina Laboratories and Regen BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Regen BioPharma are associated (or correlated) with Gemina Laboratories. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gemina Laboratories has no effect on the direction of Regen BioPharma i.e., Regen BioPharma and Gemina Laboratories go up and down completely randomly.

Pair Corralation between Regen BioPharma and Gemina Laboratories

Given the investment horizon of 90 days Regen BioPharma is expected to generate 2.4 times more return on investment than Gemina Laboratories. However, Regen BioPharma is 2.4 times more volatile than Gemina Laboratories. It trades about 0.04 of its potential returns per unit of risk. Gemina Laboratories is currently generating about 0.05 per unit of risk. If you would invest  315.00  in Regen BioPharma on September 4, 2024 and sell it today you would lose (309.49) from holding Regen BioPharma or give up 98.25% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Regen BioPharma  vs.  Gemina Laboratories

 Performance 
       Timeline  
Regen BioPharma 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Regen BioPharma are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent fundamental drivers, Regen BioPharma reported solid returns over the last few months and may actually be approaching a breakup point.
Gemina Laboratories 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Gemina Laboratories are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly unfluctuating fundamental drivers, Gemina Laboratories reported solid returns over the last few months and may actually be approaching a breakup point.

Regen BioPharma and Gemina Laboratories Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Regen BioPharma and Gemina Laboratories

The main advantage of trading using opposite Regen BioPharma and Gemina Laboratories positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Regen BioPharma position performs unexpectedly, Gemina Laboratories can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gemina Laboratories will offset losses from the drop in Gemina Laboratories' long position.
The idea behind Regen BioPharma and Gemina Laboratories pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.